Cart
sales@molnova.com
Mobocertinib
CAS No. 1847461-43-1
Mobocertinib ( tak788 )
Catalog No. M21574 CAS No. 1847461-43-1
Mobocertinib is a potent ?inhibitor of epidermal growth factor receptor (EGFR) and an antineoplastic agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 27 | Get Quote |
|
| 10MG | 42 | Get Quote |
|
| 25MG | 65 | Get Quote |
|
| 50MG | 110 | Get Quote |
|
| 100MG | 178 | Get Quote |
|
| 500MG | 464 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMobocertinib
-
NoteResearch use only not for human use.
-
Brief DescriptionMobocertinib is a potent ?inhibitor of epidermal growth factor receptor (EGFR) and an antineoplastic agent.
-
DescriptionMobocertinib is a potent ?inhibitor of epidermal growth factor receptor (EGFR) and an antineoplastic agent.
-
Synonymstak788
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1847461-43-1
-
Formula Weight585.71?
-
Molecular FormulaC32H39N7O4?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1ncc(C(=O)OC(C)C)c(n1)-c1cn(C)c2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Landon J. DURAK et al. Pharmaceutical salts of pyrimidine derivatives and method of treating disorders. WO2019222093A1.
molnova catalog
related products
-
Glaucocalyxin A
Glaucocalyxin A-SBE-β-CD could be useful with a better solubility and sustained function in drug delivery.
-
Nimotuzumab
Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).
-
AZ7550
AZ7550 is an active metabolite of AZD9291 and inhibits the activity of IGF1R with an IC50 of 1.6 μM.
